Related Experiment Videos

Killing kinetics of intracellular Afipia felis treated with amikacin

H Le Pocher1, P Brouqui, D Raoult

  • 1Unité des Rickettsies, CNRS UPRESA 6020, Faculté de Médecine, Université de la Méditerranée, Marseille, France.

Insights

Amikacin effectively kills intracellular Afipia felis bacteria by restoring phagosome-lysosome fusion in macrophages. This study highlights amikacin

Area of Science:

  • Microbiology
  • Immunology
  • Pharmacology

Background:

  • Afipia felis is a facultative intracellular bacterium that replicates within macrophages.
  • Bacterial survival relies on inhibiting phagosome-lysosome (P-L) fusion.
  • Aminoglycosides are the only antibiotics found to be bactericidal against intracellular A. felis.

Purpose of the Study:

  • To investigate the bactericidal effect of amikacin on intracellular Afipia felis.
  • To determine the relationship between amikacin treatment and the restoration of P-L fusion.
  • To elucidate the mechanisms of intracellular bacterial killing by amikacin.

Main Methods:

  • Infection of cells with Afipia felis.
  • Incubation with amikacin.
  • Quantification of intracellular bacterial load (colony-forming units/mL).
  • Assessment of phagosome-lysosome fusion restoration.

Main Results:

  • Amikacin significantly reduced intracellular A. felis counts from 8.5 x 10(5) to 3.5 x 10(2) cfu/mL within 94 hours.
  • Phagosome-lysosome fusion was restored after 30-40 hours of amikacin incubation.
  • Both bacterial reduction and P-L fusion restoration occurred concurrently.

Conclusions:

  • Amikacin exhibits potent bactericidal activity against intracellular Afipia felis.
  • Restoration of phagosome-lysosome fusion is a key mechanism in amikacin's efficacy.
  • Combined effects of direct killing and restored cellular defense contribute to bacterial clearance.

Related Concept Videos